DIH Group (DHAI) - Multiplikator Forward P/S

Tandha merek dih.com (DHAI)

Scaling the production of rehabilitation robots reduces unit costs, supporting a high operating margin for DIH Holding US, Inc. (DHAI). Patents for VR platforms and strict FDA oversight create powerful barriers to entry for competitors. P/S expectations for the company visualize the balance between share price and revenue, where the 0.00 parameter determines the metric's magnitude. The brand's technologies contribute to ESG goals by reducing treatment times and saving clinic resources.

DHAI DIH Holding: Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ing interval 19.02.2025 - 08.11.2025

DIH Holding US, Inc. - rincian analitis lan metrik utama (DHAI)

Analisis komprehensif perusahaan:DHAI (DIH Holding US, Inc.)
Sampel barang DIH Group

DIH Holding US, Inc. (DHAI) serves as a technological driver in the robotic rehabilitation segment, implementing VR systems to digitalize motor recovery. By analyzing the expected P/S multiple, an investor assesses the business's market value relative to projected revenue: inflated values reflect priced-in expansion expectations, while low levels indicate undervaluation or stagnation in the issuer's revenue growth rates.

Analisis pesaing DIH Holding US, Inc.

Multiplikator Forward P/S HCA (HCA Healthcare, Inc.)|Rasio rega marang pendapatan sing dikarepake THC (Tenet Healthcare)|FMS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep solventum.com|EHC: Multiplikator Forward P/S|UHS - Rasio kapitalisasi marang dodolan sing dikarepake|DVA (DaVita Corp) - Multiplikator Forward P/S|RDNT: Rega forward marang dodolan|Multiplikator Forward P/S OPCH|SGRY (surgerypartners.com) - Rega forward marang dodolan|Multiplikator Forward P/S PINC (Premier Inc)|National Vision - Rasio rega marang prakiraan pendapatan|PGNY - Rasio rega marang prakiraan pendapatan|ARDT - Multiplikator Forward P/S|SEM: Multiplikator Forward P/S|astranahealth.com (ASTH) - Multiplikator Forward P/S|MD (mednax.com) - Multiplikator Forward P/S|Multiplikator Forward P/S usph.com|Multiplikator Forward P/S PNTG|Rasio kapitalisasi marang dodolan sing dikarepake Organogenesis Holdings|Multiplikator Forward P/S NUTX (nutexhealth.com)|Auna SA (AUNA) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|SBC: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Jeuveau EOLS|CYH (Community Health Systems Inc) - Multiplikator forward rega marang pendapatan|SKIN: Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan MDWD|BTMD: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan The Joint Corporation (JYNT)|Multiplikator Forward P/S DocGo Inc (DCGO)|Rega forward marang dodolan P3 Health Partners, Inc.|Rasio kapitalisasi marang dodolan sing dikarepake gaintherapeutics.com (GANX)|EUDA: Multiplikator forward rega marang pendapatan|BMGL: Rasio rega marang prakiraan pendapatan|collplant.com (CLGN) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Cuprina Holdings|CCM (concordmedical.com) - Multiplikator Forward P/S|Multiplikator Forward P/S ASHS|Rasio rega marang prakiraan pendapatan MEDIROM (MRM)|ALBT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S XAGE (carmellcosmetics.com)|NIVF: Kapitalisasi marang prakiraan pendapatan|ATIP: Multiplikator forward rega marang pendapatan|CareMax Medical Group - Rasio rega marang pendapatan sing dikarepake|Kindly MD (KDLY) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan MODV|Rasio rega marang prakiraan pendapatan Novo Integrated Sciences Corp|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep SunLink Health Systems SSY|Rasio rega marang prakiraan pendapatan IMAC Corp (BACK)